Glucagon-like peptide-1 receptor agonist use and violent crime among US adults.
The rapid proliferation of Glucagon-like peptide-1 (GLP-1) receptor agonists, marketed under brand names such as Ozempic and Wegovy, has already fundamentally altered the landscape of metabolic health and obesity treatment…
New Research Suggests Popular Weight-Loss and Diabetes Drugs May Be Linked to Reduced Violent Behavior
The burgeoning popularity of GLP-1 receptor agonists, medications like Ozempic and Wegovy, initially celebrated for their efficacy in weight management and diabetes control, is now the subject of novel scientific…









